Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Download PDF
June 28, 2016
/
News
Share
the Post
Related
Posts
The Updated Pricing of Ledipasvir and Sofosbuvir Co-formulated tablets
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Up dated Generic Sofosbuvir availability and Price in India – 18 May 2015
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Generic daclatasvir (60 mg) availability and India market pricing as of 30 January 2016
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
Strategies to Secure Access to Generic HCV Medicines
Community group taking actions to enable greater access for generic HCV treatment
